Amphista Therapeutics

Developer of targeted protein degradation medicines for treating pathogenic proteins

placeCambridge, England, United Kingdom calendar_todayFounded 2017 groups12 employees language amphista.com

Registered entities

Social engagement

Social engagement: 13.2K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Advent Life Sciences, Gilde Healthcare, Forbion.

Investor typeCountShare
Venture capital433%
Private equity217%
Other / undisclosed650%

Recent activity

15 Jun 2026
Event
Decouvert and Development Europe 2026 conference
11 Jun 2026
Event
Cambridge Wide Open Week
4 Jun 2026
Event
EHA 2026 Congress
Coming soon